F. Johnson

发表

The novel phospho‐non‐steroidal anti‐inflammatory drugs, OXT‐328, MDC‐22 and MDC‐917, inhibit adjuvant‐induced arthritis in rats

B. Rigas, N. Ouyang, L. Huang, 2011, British journal of pharmacology.

A novel chemically modified curcumin reduces inflammation‐mediated connective tissue breakdown in a rat model of diabetes: periodontal and systemic effects

D. Moore, L. Golub, Hsi-Ming Lee, 2017, Journal of periodontal research.

Chemically-Modified Curcumin 2.24: A Novel Systemic Therapy for Natural Periodontitis in Dogs

J. Scaduto, L. Golub, Hsi-Ming Lee, 2020, Journal of experimental pharmacology.

Research Article a Novel Chemically Modified Curcumin Reduces Severity of Experimental Periodontal Disease in Rats: Initial Observations

L. Golub, Hsi-Ming Lee, C. Rossa, 2022 .

A Novel Chemically Modified Curcumin “Normalizes” Wound-Healing in Rats with Experimentally Induced Type I Diabetes: Initial Studies

L. Golub, Hsi-Ming Lee, Yazhou Zhang, 2016, Journal of diabetes research.

DIFFERENTIAL SUSCEPTIBILITY OF HUMAN SP-B GENETIC VARIANTS ON LUNG INJURY CAUSED BY BACTERIAL PNEUMONIA AND THE EFFECT OF A CHEMICALLY MODIFIED CURCUMIN

G. Nieman, L. Golub, R. Cooney, 2015, Shock.

Inhibition of anthrax lethal factor by curcumin and chemically modified curcumin derivatives

S. Simon, L. Golub, A. Antonelli, 2013, Journal of enzyme inhibition and medicinal chemistry.

Enhanced efficacy of chemically modified curcumin in experimental periodontitis: systemic implications

J. Scaduto, L. Golub, Hsi-Ming Lee, 2019, Journal of experimental pharmacology.

Prostate Cancer Stem Cell-Targeted Efficacy of a New-Generation Taxoid, SBT-1214 and Novel Polyenolic Zinc-Binding Curcuminoid, CMC2.24

G. Botchkina, K. Shroyer, L. Golub, 2013, PloS one.

4-Methoxycarbonyl Curcumin: A Unique Inhibitor of Both Inflammatory Mediators and Periodontal Inflammation

L. Golub, Hsi-Ming Lee, T. Sorsa, 2013, Mediators of inflammation.

Novel Chemically Modified Curcumin (CMC) Derivatives Inhibit Tyrosinase Activity and Melanin Synthesis in B16F10 Mouse Melanoma Cells

S. Simon, S. Goenka, F. Johnson, 2021, Biomolecules.

Design, synthesis and biological activity of new polyenolic inhibitors of matrix metalloproteinases: a focus on chemically-modified curcumins.

L. Golub, Hsi-Ming Lee, Ying Gu, 2012, Current medicinal chemistry.

The Maximum-Tolerated Dose and Pharmacokinetics of a Novel Chemically Modified Curcumin in Rats

L. Golub, Hsi-Ming Lee, Ying Gu, 2022, Journal of experimental pharmacology.

Differential effects of natural Curcumin and chemically modified curcumin on inflammation and bone resorption in model of experimental periodontitis.

P. Cerri, F. Curylofo-Zotti, L. Golub, 2018, Archives of oral biology.

A Chemically Modified Curcumin (CMC 2.24) Inhibits Nuclear Factor κB Activation and Inflammatory Bone Loss in Murine Models of LPS-Induced Experimental Periodontitis and Diabetes-Associated Natural Periodontitis

L. Golub, Hsi-Ming Lee, C. Rossa, 2017, Inflammation.

Fall 9-24-2013 Prostate Cancer Stem Cell-Targeted Efficacy of a New-Generation Taxoid , SBT-1214 and Novel Polyenolic Zinc-Binding Curcuminoid , CMC 2 . 24

Agnieszka, G. Botchkina, K. Shroyer, 2019 .

The Advent of COVID-19; Periodontal Research Has Identified Therapeutic Targets for Severe Respiratory Disease; an Example of Parallel Biomedical Research Agendas

M. Glogauer, L. Golub, N. Fine, 2021, Frontiers in Dental Medicine.

Bioactivation of the tobacco carcinogens 4-aminobiphenyl (4-ABP) and 2-amino-9H-pyrido[2,3-b]indole (AαC) in human bladder RT4 cells

R. Bonala, R. Turesky, L. V. von Weymarn, 2019, Archives of Toxicology.

Bioactivation mechanisms of N‐hydroxyaristolactams: Nitroreduction metabolites of aristolochic acids

A. Grollman, R. Bonala, Y. Okuno, 2019, Environmental and molecular mutagenesis.

Efficacy of a Novel Pleiotropic MMP-Inhibitor, CMC2.24, in a Long-Term Diabetes Rat Model with Severe Hyperglycemia-Induced Oral Bone Loss

L. Golub, Hsi-Ming Lee, Ying Gu, 2023, Journal of inflammation research.

F. Curylofo-Zotti, L. Golub, Hsi-Ming Lee, 2017, Inflammation.

Characterization of the tumor-promoting activity of m-chloroperoxybenzoic acid in SENCAR mouse skin and its inhibition by gallotannin, oligomeric proanthocyanidin, and their monomeric units.

R. Hemingway, G. Chen, F. Johnson, 1996, International journal of oncology.

A Novel Chemically-Modified Curcumin 2.24: Short-Term Systemic Therapy for Natural Periodontitis in Dogs

J. Scaduto, L. Golub, Hsi-Ming Lee, 2021, Frontiers in Dental Medicine.

A novel tricarbonylmethane agent (CMC2.24) reduces human pancreatic tumor growth in mice by targeting Ras

L. Golub, Joseph F LaComb, M. Nemesure, 2018, Molecular carcinogenesis.

Dose-response assessment of chemically modified curcumin in experimental periodontitis.

L. Golub, L. C. Spolidorio, C. Rossa, 2018, Journal of periodontology.

A Novel Modified-Curcumin Promotes Resolvin-Like Activity and Reduces Bone Loss in Diabetes-Induced Experimental Periodontitis

L. Golub, Hsi-Ming Lee, Ying Gu, 2021, Journal of inflammation research.

A Novel Chemically-Modified Curcumin 2.24: Short-term Systemic Treatment for Natural Periodontitis in Dogs

J. Scaduto, L. Golub, Hsi-Ming Lee, 2020 .

A novel modified-curcumin 2.24 resolves inflammation by promoting M2 macrophage polarization

Hsi-Ming Lee, Ying Gu, F. Johnson, 2023, Scientific reports.

A Novel Chemically Modified Curcumin “Normalizes” Wound-Healing in Rats with Experimentally Induced Type I Diabetes: Initial Studies

L. Golub, Hsi-Ming Lee, Yazhou Zhang, 2016, Journal of diabetes research.

A Novel Chemically Modified Curcumin “Normalizes” Wound-Healing in Rats with Experimentally Induced Type I Diabetes: Initial Studies

L. Golub, Hsi-Ming Lee, Yazhou Zhang, 2016, Journal of diabetes research.

pKa, zinc- and serum albumin-binding of curcumin and two novel biologically-active chemically-modified curcumins.

L. Golub, F. Johnson, A. Wishnia, 2012, Current medicinal chemistry.